Lupron depot-PED 11.25 MG kits
Ended Awarded
- Contract number
- SPE2DR26FT109
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,001
Award facts
- Contract value 100% obligated
- $26,001.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,001.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot-Ped 11.25 mg kits, with an ultimate completion date of October 21, 2025. This was a competitive, non-set-aside award issued on October 20, 2025. AmerisourceBergen will perform this contract at its corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a wide range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Lupron Depot-Ped, a specialized pediatric formulation of leuprolide acetate used in treating certain endocrine disorders in children, represents the type of specialized medication within AmerisourceBergen's extensive portfolio of brand-name drugs, generics, vaccines, and medical devices. The company's consistent track record of competitive awards and firm fixed-price delivery orders across multiple therapeutic domains demonstrates its capability to meet federal medical supply requirements through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26FT109?
SPE2DR26FT109 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FT109 worth?
The government has obligated $26,001 on SPE2DR26FT109.
Is contract SPE2DR26FT109 an order under another contract?
Yes. SPE2DR26FT109 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT109 competed?
The extent of competition for SPE2DR26FT109 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award